Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $515.00
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price boosted by JPMorgan Chase & Co. from $512.00 to $515.00 in a report released on Tuesday,Benzinga reports. The firm currently has an overweight rating on the pharmaceutical company’s stock. A number of other research firms also recently commented on VRTX. HC Wainwright reissued a “buy” […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price boosted by JPMorgan Chase & Co. from $512.00 to $515.00 in a report released on Tuesday,Benzinga reports. The firm currently has an overweight rating on the pharmaceutical company’s stock. A number of other research firms also recently commented on VRTX. HC Wainwright reissued a “buy” […]
